PerpEquitiesEquity
OSCR perpetual futures
Oscar Health, Inc. tracked across crypto venues with normalized contract specs.
Price chart
31.63▼ 1.22%
31.7031.8031.9032.00
01:32 PM01:46 PM02:00 PM02:13 PM02:27 PM
24/7 perp mark · OKX (OSCR/USDT)
Auto: market closed → highest-volume perp venue
Trading data
Perpetual market activity
Venues
1
Live markets
1/1
24h volume
$76k
Open interest
$8k
Best liquidity
$33k
OKX
Tightest spread
+15.9 bps
OKX
Highest volume
$76k
OKX
Settlement mix
USDT · 1/1
Best Liquidity
OSCRTightest Spread
OSCRHighest Volume
OSCRCompany data
Company fundamentals
Market cap
$8.3B
Updated 1h ago
Revenue
$13.3B
Trailing 12 months
Net income
$-39.4M
Trailing 12 months
Free cash flow
$2.8B
Trailing 12 months
Profit margin
-0.3%
P/E
-84.5
P/S
0.6
Revenue estimate
$18.5B
Next fiscal year
Revenue growth
+58%
Next fiscal year
Fundamental detail
Annual + quarterlyLatest revenue$11.7B
Net margin-3.8%
Free cash flow$1.1B
Net debt$-2.3B
PeriodRevenueGrowthNet incomeFCF
2020$589.6M+6%$-406.8M$208.7M
2021$1.9B+226%$-572.6M$-207.6M
2022$4.1B+115%$-606.3M$351.3M
2023$5.9B+42%$-270.7M$-297.7M
2024$9.2B+57%$25.4M$950.3M
2025$11.7B+28%$-443.2M$1.1B
PeriodGross marginOperating marginNet marginROEROA
2020+100.0%-68.8%-69.0%+31.4%-17.9%
2021+100.0%-29.7%-29.8%-41.3%-17.2%
2022+100.0%-14.8%-14.7%-68.1%-13.4%
2023+20.8%-4.0%-4.6%-33.7%-7.5%
2024+20.1%+0.6%+0.3%+2.5%+0.5%
2025+14.4%-3.4%-3.8%-45.3%-7.0%
PeriodCashDebtNet debtCurrent ratio
2020$826.3M$142.5M$-683.8M0.00
2021$1.1B$0.0$-1.1B1.71
2022$1.6B$298.0M$-1.3B1.26
2023$1.9B$298.8M$-1.6B-11.82
2024$1.5B$299.6M$-1.2B0.90
2025$2.8B$430.1M$-2.3B0.95
PeriodMarket capEnterprise valueP/SP/E
2020$8.3B$7.6B14.1-20.5
2021$1.4B$300.9M0.7-2.5
2022$522.7M$-737.9M0.1-0.9
2023$2.0B$456.6M0.3-7.5
2024$3.2B$2.0B0.4122.2
2025$3.8B$1.4B0.3-8.5
PeriodRevenueGrowthNet incomeFCF
Q2 2024$2.2B+46%$56.2M$489.6M
Q3 2024$2.4B+68%$-54.6M$-507.7M
Q4 2024$2.4B+67%$-153.5M$340.0M
Q1 2025$3.0B+42%$275.3M$869.5M
Q2 2025$2.9B+29%$-228.4M$499.8M
Q3 2025$3.0B+23%$-137.4M$-973.7M
Q4 2025$2.8B+17%$-352.6M$662.8M
Q1 2026$4.6B+53%$679.0M$2.6B
PeriodGross marginOperating marginNet marginROEROA
Q2 2024+100.0%+2.7%+2.5%+4.9%+1.1%
Q3 2024+100.0%-2.2%-2.3%-4.7%-1.2%
Q4 2024+13.7%-6.2%-6.4%-15.1%-3.2%
Q1 2025+25.8%+9.8%+9.0%+20.6%+4.7%
Q2 2025+10.9%-8.0%-8.0%-19.7%-3.6%
Q3 2025+13.4%-4.3%-4.6%-13.4%-2.4%
Q4 2025+6.6%-11.9%-12.6%-36.1%-5.6%
Q1 2026+30.5%+15.2%+14.6%+40.8%+7.3%
PeriodCashDebtNet debtCurrent ratio
Q2 2024$2.3B$299.2M$-2.0B-14.71
Q3 2024$1.2B$299.4M$-906.8M0.80
Q4 2024$1.5B$299.6M$-1.2B0.82
Q1 2025$2.2B$299.7M$-1.9B0.91
Q2 2025$2.6B$299.9M$-2.3B0.89
Q3 2025$2.1B$686.3M$-1.5B1.10
Q4 2025$2.8B$430.1M$-2.3B1.10
Q1 2026$4.8B$430.9M$-4.4B1.09
PeriodMarket capEnterprise valueP/SP/E
Q2 2024$3.8B$1.8B1.716.5
Q3 2024$5.2B$4.2B2.1-24.1
Q4 2024$3.2B$2.0B1.4-5.4
Q1 2025$3.3B$1.4B1.13.0
Q2 2025$5.4B$3.1B1.9-6.0
Q3 2025$4.9B$3.4B1.6-8.9
Q4 2025$4.1B$1.7B1.5-2.9
Q1 2026$3.4B$-954.1M0.71.3
Refreshed 1h ago
Research data
Estimates, events and peers
Estimates
6 periodsFY 2026$18.5B+58%7 analysts
FY 2027$19.9B+70%7 analysts
FY 2028$22.2B+90%6 analysts
FY 2029$25.3B+116%5 analysts
FY 2030$28.2B+141%3 analysts
Q1 2027$5.1B+10%2 analysts
Events
Earnings · dividends · splits2026-08-05EarningsRevenue est. $4.7B
2026-05-06EarningsRevenue est. $4.9B
2026-02-10EarningsRevenue est. $3.1B
2025-11-06EarningsRevenue est. $3.1B
2025-08-06EarningsRevenue est. $3.1B
2025-05-07EarningsRevenue est. $2.8B